LEXINGTON, Mass.-– N-of-One, the leading provider of clinical interpretation for precision medicine in oncology, today announced an agreement with Mayo Clinic to provide access to clinical interpretation information to aid in highly complex molecular diagnostics. Under the terms of the agreement, in select cases, N-of-One solutions will assist in the identification of biological and clinical […]
Alameda, CA.–– Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMCTM) technology for clinical diagnostics and scientific discovery, today announced the appointment of Peter Heseltine, M.B., B.Ch., B.A.O., as Chief Medical Officer. At Singulex, Dr. Heseltine will have overall responsibility for clinical strategy, including scientific and medical affairs. “Peter brings a wealth […]
BOULDER, CO — InDevR, a Boulder-based life science company, has received a new NIH SBIR grant to develop an innovative optical system that will automate interpretation of hemagglutination assays. The 2-year Phase 1 grant (R43AI106054) is sponsored by the National Institute of Allergy and Infectious Diseases. Hemagglutination and hemagglutination inhibition assays are widely used to […]
Tute Genomics has announced that they will join the Global Alliance for Genomics and Health, a group of the world’s leading genomics and healthcare organizations with a shared mission to accelerate the sharing of genomic data for healthcare by developing ethical and secure standards. As a partner with the Global Alliance, Tute will work to […]
TEL AVIV, Israel — — For the first time in the Israeli market, two major corporations will cooperate to help identify potential breakthrough startups. Microsoft and BD (Becton, Dickinson and Company), a leading global medical technology company, are working together to establish a unique accelerator experience for startups creating advancements for the healthcare industry. The […]
LEXINGTON, Mass.-– N-of-One, the leader in clinical interpretation for precision medicine in oncology, today announced an agreement with Guardant Health to provide clinical decision support for Guardant360™, a breakthrough blood test that enables next generation sequencing of solid tumor DNA. Financial terms of the agreement are not disclosed. Guardant360 is the first pan-cancer blood test […]
BURLINGTON, N.C.– Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the availability of the xTAG® CYP2D6 Kit v3 from Luminex Corporation (NASDAQ: LMNX). The xTAG CYP2D6 Kit v3 is an FDA cleared qualitative genotyping assay that aids clinicians in determining strategies for therapeutics metabolized by the CYP2D6 gene product. CYP2D6 is one of […]
Owlstone have been awarded an SBRI Healthcare development contract, which will fund in-house development and testing of Owlstone’s Lonestar Analyzer, for use in the diagnosis of lung cancer. Following the Nokia Sensing XChallenge distinguished award secured in 2013, this funding will further efforts to apply Owlstone’s chemical sensing technology in the medical sector. Owlstone’s medical […]
Woburn, MA — PathoGenetix, Inc. has developed and validated a protocol for the identification and subtyping of bacteria directly from human clinical stool samples without prior cultural isolation. The protocol, which runs on the RESOLUTION™ System, enables public health and microbiome research laboratories to determine serotype and strain type information for multiple bacteria directly from […]
Minneapolis — Techne Corporation (NASDAQ:TECH), (d/b/a Bio-Techne) announces that Harold Wiens, a 30+ year veteran of 3M company, has joined the board of Bio-Techne, adding additional seasoned global business experience to a well-established team. Harold graduated from Michigan Technological University with a Bachelor’s degree in Mechanical Engineering in 1968. He began working for 3M in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
